These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 10469279)
1. Interleukin-17: A new bone acting cytokine in vitro. Van bezooijen RL; Farih-Sips HC; Papapoulos SE; Löwik CW J Bone Miner Res; 1999 Sep; 14(9):1513-21. PubMed ID: 10469279 [TBL] [Abstract][Full Text] [Related]
2. IL-6 is produced by osteoblasts and induces bone resorption. Ishimi Y; Miyaura C; Jin CH; Akatsu T; Abe E; Nakamura Y; Yamaguchi A; Yoshiki S; Matsuda T; Hirano T J Immunol; 1990 Nov; 145(10):3297-303. PubMed ID: 2121824 [TBL] [Abstract][Full Text] [Related]
3. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption. Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651 [TBL] [Abstract][Full Text] [Related]
4. Effects of TGF-beta, TNF-alpha, IL-beta and IL-6 alone or in combination, and tyrosine kinase inhibitor on cyclooxygenase expression, prostaglandin E2 production and bone resorption in mouse calvarial bone cells. Park YG; Kang SK; Kim WJ; Lee YC; Kim CH Int J Biochem Cell Biol; 2004 Nov; 36(11):2270-80. PubMed ID: 15313472 [TBL] [Abstract][Full Text] [Related]
5. Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism. Ishimi Y; Abe E; Jin CH; Miyaura C; Hong MH; Oshida M; Kurosawa H; Yamaguchi Y; Tomida M; Hozumi M J Cell Physiol; 1992 Jul; 152(1):71-8. PubMed ID: 1618924 [TBL] [Abstract][Full Text] [Related]
6. TNF-alpha and IL-1beta suppress N-cadherin expression in MC3T3-E1 cells. Tsutsumimoto T; Kawasaki S; Ebara S; Takaoka K J Bone Miner Res; 1999 Oct; 14(10):1751-60. PubMed ID: 10491223 [TBL] [Abstract][Full Text] [Related]
7. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model. Chabaud M; Miossec P Arthritis Rheum; 2001 Jun; 44(6):1293-303. PubMed ID: 11407688 [TBL] [Abstract][Full Text] [Related]
8. IL-13 and IL-4 inhibit bone resorption by suppressing cyclooxygenase-2-dependent prostaglandin synthesis in osteoblasts. Onoe Y; Miyaura C; Kaminakayashiki T; Nagai Y; Noguchi K; Chen QR; Seo H; Ohta H; Nozawa S; Kudo I; Suda T J Immunol; 1996 Jan; 156(2):758-64. PubMed ID: 8543830 [TBL] [Abstract][Full Text] [Related]
9. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: fibroblast-mediated pathologic bone resorption. Tunyogi-Csapo M; Kis-Toth K; Radacs M; Farkas B; Jacobs JJ; Finnegan A; Mikecz K; Glant TT Arthritis Rheum; 2008 Aug; 58(8):2397-408. PubMed ID: 18668542 [TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokines and chemokine production and expression by human osteoblasts isolated from patients with rheumatoid arthritis and osteoarthritis. Lisignoli G; Toneguzzi S; Pozzi C; Piacentini A; Riccio M; Ferruzzi A; Gualtieri G; Facchini A J Rheumatol; 1999 Apr; 26(4):791-9. PubMed ID: 10229398 [TBL] [Abstract][Full Text] [Related]
11. Regulation of interleukin-6 expression in human osteoblastic cells in vitro. Hierl T; Börcsök I; Sommer U; Ziegler R; Kasperk C Exp Clin Endocrinol Diabetes; 1998; 106(4):324-33. PubMed ID: 9792466 [TBL] [Abstract][Full Text] [Related]
13. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. Shen F; Ruddy MJ; Plamondon P; Gaffen SL J Leukoc Biol; 2005 Mar; 77(3):388-99. PubMed ID: 15591425 [TBL] [Abstract][Full Text] [Related]
14. Effect of interleukin-17 on nitric oxide production and osteoclastic bone resorption: is there dependency on nuclear factor-kappaB and receptor activator of nuclear factor kappaB (RANK)/RANK ligand signaling? Van Bezooijen RL; Papapoulos SE; Löwik CW Bone; 2001 Apr; 28(4):378-86. PubMed ID: 11336918 [TBL] [Abstract][Full Text] [Related]
15. Herbal formulation, Yukmi-jihang-tang-Jahage, regulates bone resorption by inhibition of phosphorylation mediated by tyrosine kinase Src and cyclooxygenase expression. Jin UH; Kim DI; Lee TK; Lee DN; Kim JK; Lee IS; Kim CH J Ethnopharmacol; 2006 Jul; 106(3):333-43. PubMed ID: 16513308 [TBL] [Abstract][Full Text] [Related]
16. IL-1- and TNF-induced bone resorption is mediated by p38 mitogen activated protein kinase. Kumar S; Votta BJ; Rieman DJ; Badger AM; Gowen M; Lee JC J Cell Physiol; 2001 Jun; 187(3):294-303. PubMed ID: 11319753 [TBL] [Abstract][Full Text] [Related]
17. The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line. Hofbauer LC; Ten RM; Khosla S J Bone Miner Res; 1999 Aug; 14(8):1330-7. PubMed ID: 10457265 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor. Vargas SJ; Naprta A; Glaccum M; Lee SK; Kalinowski J; Lorenzo JA J Bone Miner Res; 1996 Nov; 11(11):1736-44. PubMed ID: 8915781 [TBL] [Abstract][Full Text] [Related]
19. Involvement of PKC-beta in PTH, TNF-alpha, and IL-1 beta effects on IL-6 promoter in osteoblastic cells and on PTH-stimulated bone resorption. Radeff JM; Nagy Z; Stern PH Exp Cell Res; 2001 Aug; 268(2):179-88. PubMed ID: 11478844 [TBL] [Abstract][Full Text] [Related]
20. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts. Yu X; Huang Y; Collin-Osdoby P; Osdoby P J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]